(Q73744768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

metastatic breast cancer

1 reference

J Y Pierga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Robain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Jouve

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Asselain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V Diéras

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Beuzeboc

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T Palangié

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T Dorval

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J M Extra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Scholl

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Pouillart

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

231-237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

Should we dream the impossible dream? The meaning of long-term survival in metastatic breast cancer

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Why does a higher response rate to chemotherapy correlate poorly with improved survival?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Classification of patients with disseminated cancer of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Multivariate analysis of prognostic factors in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

On the relationship between response to treatment and survival time

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment: prognostic factors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Chemotherapy of advanced breast cancer: outcome and prognostic factors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Survival after first recurrence in breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Chemotherapy response criteria in malignant glioma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008330527188

7 January 2021

Identifiers

DOI

10.1023/A:1008330527188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11300330%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference